Nordic Pancreatic Cancer Trial (NorPACT) - 1

NCT02919787 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: 5-FU
DRUG: Oxaliplatine
DRUG: Irinotecan
PROCEDURE: Pancreatic surgery
DRUG: 5-FU
DRUG: Oxaliplatine
DRUG: Irinotecan

Sponsor

Oslo University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]